Am J Transplant, Volume 19, Suppl 3 Archives - Page 182 of 214 - ATC Abstracts

2019 American Transplant Congress
Quality of Life in Tolerant Living Donor Kidney Transplants vs. Standard of Care
D. Tollerud¹, J. Leventhal², J. Galvin², J. Mathew², L. Gallon², D. Stare², J. Miller², M. Abecassis², S. Ildstad³
¹Regenerex, Inc., Louisville, KY, ²Northwestern U, Chicago, IL, ³U of Louisville, Louisville, KY
*Purpose: 37 subjects have been transplanted since 2009 in a phase 2 protocol to induce tolerance in recipients of living donor renal allografts. The protocol…
2019 American Transplant Congress
Chylous Ascites Following Laparoscopic Live Donor Nephrectomy: A New Improved Treatment Paradigm
L. Dale¹, R. Sandoval², L. E. Ratner²
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Surgery, Columbia University Medical Center, New York, NY
*Purpose: To illustrate prompt, initial placement of a percutaneous drain is an alternative treatment of chylous ascites after laparoscopic live donor nephrectomy.*Methods: We identified three…
2019 American Transplant Congress
Complex Live Donor Anatomy Does Not Preclude Kidney Transplantation
P. Veitch, T. Brown, A. Courtney, J. McDaid
Transplant Department, Belfast City Hospital, Belfast, United Kingdom
*Purpose: Living donor (LD) kidney transplantation is the optimum form of renal replacement therapy for suitable patients. Decline of otherwise suitable potential donors on the…
2019 American Transplant Congress
Clinical Impact of Spontaenous Portosystemic Shunts on the Short Term Outcome of Liver Transplantation
E. A. Rodriguez¹, R. M. Perez², N. Zhang³, E. S. Lim³, C. R. Miller⁴, M. A. Schwartz², A. J. McGirr⁴, A. Srinivasan⁵, W. R. Hewitt⁵, A. C. Silva⁴, J. Rakela¹, H. E. Vargas¹
¹Transplant Hepatology, Mayo Clinic Arizona, Phoenix, AZ, ²Mayo Clinic School of Medicine, Mayo Clinic Arizona, Phoenix, AZ, ³Division of Health Sciences Research, Mayo Clinic Arizona, Phoenix, AZ, ⁴Radiology, Mayo Clinic Arizona, Phoenix, AZ, ⁵Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: The aim of our study was to compare Liver Transplant (LT) candidates with and without spontaneous portosystemic shunts (SPSS) and assess their impact on…
2019 American Transplant Congress
Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation
S. Alghamdi, O. Altayar, T. Zhu, A. Bayudan, J. Fleckenstein, M. Lisker-Melman, J. Crippin, A. Flores
Washington University in St Louis, Saint Louis, MO
*Purpose: Cardiovascular (CV) disease is a leading cause of mortality 1 year after liver transplantation (LT). We aimed to assess the effect of treating CV…
2019 American Transplant Congress
Absorbable Mesh Placement to Prevent Incisional Hernias after Donor Hepatectomy
D. von Ahrens¹, R. Hwang², T. Kato², J. Emond², A. Griesemer², B. Samstein¹
¹Surgery, New York Presbyterian Weill Cornell, New York, NY, ²Surgery, New York Presbyterian Columbia University Medical Center, New York, NY
*Purpose: Thirty to fifty percent of complications in donor hepatectomy appear to be related to abdominal wall trauma, including hernia, bowel obstruction, and chronic abdominal…
2019 American Transplant Congress
Insertion of Internal Stent in Duct-to-Duct Biliary Reconstruction to Reduce Bile Duct Complication in Living Donor Liver Transplantation
H. Choi¹, G. Na²
¹Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of, ²Surgery, Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, Korea, Republic of
*Purpose: Because of the innovations in surgical and postoperative surgical treatment of donors and recipients during the past decade, living donor liver transplantation (LDLT) is…
2019 American Transplant Congress
Anti-Complement Component 5 Antibody Based Immunosuppression Induced Accommodation in ABO Incompatible Heart Transplantation
S. Park¹, S. Lee¹, J. Hwang¹, J. Ryu², T. Koo², C. Ahn³, J. Yang⁴
¹Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea, Republic of, ²Transplantation Center, Seoul National University Hospital, Seoul, Korea, Republic of, ³Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of, ⁴Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Plasmapheresis in combination with immunoglobulin and rituximab is often used to induce accommodation in ABO-incompatible (ABOi) living-donor transplantation; however, this regimen cannot be applied…
2019 American Transplant Congress
Cellular Sources of Cytokine Production during Cold Ischemia Induced AKI after Kidney Transplant
S. Jain¹, R. Plenter², T. Nydam², A. Jani¹
¹Renal Division, University of Colorado, Aurora, CO, ²Transplant Microsurgery Program, University of Colorado, Aurora, CO
*Purpose: Delayed graft function portends reduced 5-year graft survival and is associated with prolonged cold ischemia (CI). The aim of this study was to determine…
2019 American Transplant Congress
Expansion of Myeloid Derived Suppressor Cells Following Alum Administration
A. G. Cuenca, N. J. Feeney, K. Deng, C. G. Rickert, J. F. Markmann
Massachusetts General Hospital, Boston, MA
*Purpose: Immunosuppressive medications, such as calcineurin inhibitors, are critical to the survival of the transplant allograft but come with significant morbidity to the recipient and…